AstraZeneca
Isabell Gruebner is Senior Director of Enterprise AI Products at AstraZeneca, where she delivers advanced AI systems that enable strategic decision-making across the pharma ecosystem. She specialises in applying state-of-the-art methods, including graph machine learning, computer vision, generative AI, and agentic workflows, in enterprise settings where adoption and governance are as critical as technical capability.
With a PhD in Chemistry from the University of Oxford, Isabell brings a first-principles approach to AI strategy. She believes AI should deliver lasting value to existing workflows with minimal disruption and pursues simple, effective solutions that deliver tangible results. She has led cross-functional initiatives bridging AI possibilities with operational and regulatory realities.
No posts were found for provided query parameters.